Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcus Biosciences Inc.(RCUS) | 31,424,760 | 31,424,760 | 0 | 678,775 | 968,825 | 58.76% | +290,051 |
| Assembly Biosciences Inc. | 4,505,391 | 4,977,089 | +471,698 | 125,025 | 136,770 | 8.30% | +11,746 |
| Kyverna Therapeutics Inc.(KYTX) | 4,126,119 | 4,126,119 | 0 | 35,608 | 36,764 | 2.23% | +1,155 |
| Xilio Therapeutics Inc.(XLO) | 650,389 | 650,389 | 0 | 5,470 | 6,231 | 0.38% | +761 |
| Lakefront Biotherapeutics(LKFT) | 16,707,477 | 16,707,477 | 0 | 501,224 | 500,158 | 30.34% | -1,067 |
| Arcellx Inc COMMON STOCK | 6,720,803 | 0 | -6,720,803 | 771,683 | 0 | — | -771,683 |